IAV HA (RBS) Specific Neutra™ Antibody (V3S-0923-XY36), Human IgG (CAT#: V3S-0923-XY36)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This is a neutralizing antibody clone AVFIuIgG03 specific for IAV HA (influenza A virus hemagglutinin), derived from human. AVFluIgG03 neutralizes the virus by directly blocking the attachment of the virus to the host cell. It has reasonably great potency and is able to neutralize 11 out the 17 pseudoviruses. This product has been determined using Enzyme-linked immunosorbent assay and Neutralization assay.
Clonality Monoclonal
Host Species Human
Target Species IAV
Epitope The epitope of AVFluIgG03 consisted of 17 external residues in the RBS at the membrane-distal end of the HA spike. A distinct set of critical residues consists of E130, S133, K156 and N159.
Neutralization Mechanism AVFluIgG03 blocks the attachment of the virus to the host cell.
IC50 0.620±1.477 μg/mL
Isotype Human IgG

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; Neut
Application Notes Neutralization assay (Neut): Twofold dilutions of each mAb was incubated with pseudovirus at the final volume of 100 μL at 37°C for 1 h.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target IAV HA
Alternative Name Hemagglutinin
Research Area Infectious Disease
Related Disease Influenza
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry